Science Translational Medicine, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation

Karagkouni D., Brake M., Patell R. et al.

Clinical Cancer Research, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas

Low J., Chong W., Hui E. et al.

Expert Review of Molecular Diagnostics, 2026
Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank

Liu M., Ma H., Zhou H. et al.

Kidney Medicine, 2026
Association of Cystatin C- and Creatinine-Based eGFR With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

Roehm B., Zhang X., Yang J. et al.

Nature Medicine, 2026
Plasma proteomic signatures of cellular aging predict human disease

Ding D., Bot V., Chen K. et al.

Annals of the Rheumatic Diseases, 2026
Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

Kim H., Kim M., Kim S. et al.

Journal of the National Cancer Center, 2026
Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer

Yang L., Xu H., Zhang C. et al.

Journal of Global Health, 2026
Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men

Li H., Zhang Y., Chen L. et al.

Cardiovascular Diabetology, 2026
Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3

Chen X., Tang H., Xu Z. et al.

Frontiers in Cardiovascular Medicine, 2026
Extracorporeal cardiac shock wave therapy modulates post-infarction neovascularization via CAC-mediated pro-angiogenic effects and modulation of the S100A4/CSF2/FOXO1 protein network

Li Y., Li H., Liu C. et al.

Psychiatry Research, 2026
Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder

Sun L., Bi J., Sun J.

Journal of Extracellular Vesicles, 2026
Intranasal Delivery of Bacterial Extracellular Vesicles Enables RNA Cargo Entry Into the Brain

Ha J., Kim S., Choi S. et al.

Molecular Psychiatry, 2026
Plasma proteomics of sleep traits reveals systemic immune-metabolic pathways and genetically prioritized proteins

Chen H., Wang X., Chen W. et al.

Journal of Inflammation Research, 2026
Identification of Biomarker in Kidney Stone Disease by Integrating Transcriptomics and Olink Proteomics: A Case–Control Study

Wang N., Zhou B., Xu C. et al.

Ophthalmology Science, 2026
Plasma proteomics identifies proteins and pathways associated with cataract: a prospective cohort study

Zhang Y., Yu J., Peng Y. et al.

Sports Medicine - Open, 2026
Project FURTHER: A Physiological, Biomechanical, and Psychosocial Profile of an All-Female 6-Day Ultramarathon Race

Caldwell H., Stellingwerff T., Gathercole R. et al.

Human Mutation, 2026
CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation

Jiang Z., Ma P., Zhang S. et al.

Med Research, 2026
Prioritizing Modifiable Risk Factors for Cardiovascular Diseases in Adults With Hypertension: A Prospective Cohort Study

Wei S., Zheng D., Chen L. et al.

Frontiers in Immunology, 2026
Inhibitory impact of A1 and A2 cow’s milk on human peripheral blood mononuclear cells identifies TOM1 as a candidate anti-inflammatory mediator

Flad L., Weißer T., Liedl J. et al.

eBioMedicine, 2026
The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention

Yin Q., Ding M., Tang Y. et al.